{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:10:26Z","timestamp":1778915426139,"version":"3.51.4"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,10,4]],"date-time":"2006-10-04T00:00:00Z","timestamp":1159920000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1186\/1743-8454-3-11","type":"journal-article","created":{"date-parts":[[2006,10,4]],"date-time":"2006-10-04T18:27:46Z","timestamp":1159986466000},"source":"Crossref","is-referenced-by-count":41,"title":["Biomarkers in chronic adult hydrocephalus"],"prefix":"10.1186","volume":"3","author":[{"given":"Andrew","family":"Tarnaris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence D","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil D","family":"Kitchen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,10,4]]},"reference":[{"issue":"7","key":"151_CR1","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/jnnp.53.7.564","volume":"53","author":"J Vanneste","year":"1990","unstructured":"Vanneste J, van Acker R: Normal pressure hydrocephalus: did publications alter management?. J Neurol Neurosurg Psychiatry. 1990, 53 (7): 564-568.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"151_CR2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.7326\/0003-4819-100-3-417","volume":"100","author":"EB Larson","year":"1984","unstructured":"Larson EB, Reifler BV, Featherstone HJ, English DR: Dementia in elderly outpatients: a prospective study. Ann Intern Med. 1984, 100 (3): 417-423.","journal-title":"Ann Intern Med"},{"issue":"2","key":"151_CR3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1600-0404.2005.00451.x","volume":"112","author":"M Tisell","year":"2005","unstructured":"Tisell M, Hoglund M, Wikkelso C: National and regional incidence of surgery for adult hydrocephalus in Sweden. Acta Neurol Scand. 2005, 112 (2): 72-75. 10.1111\/j.1600-0404.2005.00451.x.","journal-title":"Acta Neurol Scand"},{"issue":"14","key":"151_CR4","first-page":"1681","volume":"98","author":"M Hoglund","year":"2001","unstructured":"Hoglund M, Tisell M, Wikkelso C: [Incidence of surgery for hydrocephalus in adults surveyed: same number afflicted by hydrocephalus as by multiple sclerosis]. Lakartidningen. 2001, 98 (14): 1681-1685.","journal-title":"Lakartidningen"},{"issue":"10","key":"151_CR5","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/archneur.1995.00540340109020","volume":"52","author":"C Trenkwalder","year":"1995","unstructured":"Trenkwalder C, Schwarz J, Gebhard J, Ruland D, Trenkwalder P, Hense HW, Oertel WH: Starnberg trial on epidemiology of Parkinsonism and hypertension in the elderly. Prevalence of Parkinson's disease and related disorders assessed by a door-to-door survey of inhabitants older than 65 years. Arch Neurol. 1995, 52 (10): 1017-1022.","journal-title":"Arch Neurol"},{"issue":"4","key":"151_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0022-510X(65)90016-X","volume":"2","author":"S Hakim","year":"1965","unstructured":"Hakim S, Adams RD: The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics. J Neurol Sci. 1965, 2 (4): 307-327. 10.1016\/0022-510X(65)90016-X.","journal-title":"J Neurol Sci"},{"key":"151_CR7","doi-asserted-by":"crossref","unstructured":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001, 69 (3): 89-95. 10.1067\/mcp.2001.113989.","DOI":"10.1067\/mcp.2001.113989"},{"issue":"3","key":"151_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.clineuro.2004.02.008","volume":"106","author":"A Miller","year":"2004","unstructured":"Miller A, Glass-Marmor L, Abraham M, Grossman I, Shapiro S, Galboiz Y: Bio-markers of disease activity and response to therapy in multiple sclerosis. Clin Neurol Neurosurg. 2004, 106 (3): 249-254. 10.1016\/j.clineuro.2004.02.008.","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"151_CR9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1602\/neurorx.1.3.323","volume":"1","author":"A Feigin","year":"2004","unstructured":"Feigin A: Evidence from biomarkers and surrogate endpoints. NeuroRx. 2004, 1 (3): 323-330. 10.1602\/neurorx.1.3.323.","journal-title":"NeuroRx"},{"issue":"1","key":"151_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000089137","volume":"21","author":"I Blasko","year":"2006","unstructured":"Blasko I, Lederer W, Oberbauer H, Walch T, Kemmler G, Hinterhuber H, Marksteiner J, Humpel C: Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias. Dement Geriatr Cogn Disord. 2006, 21 (1): 9-15. 10.1159\/000089137.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"151_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.clineuro.2004.10.011","volume":"107","author":"N Andreasen","year":"2005","unstructured":"Andreasen N, Blennow K: CSF biomarkers for mild cognitive impairment and early Alzheimer's disease. Clin Neurol Neurosurg. 2005, 107 (3): 165-173. 10.1016\/j.clineuro.2004.10.011.","journal-title":"Clin Neurol Neurosurg"},{"issue":"5","key":"151_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/sj.cr.7290235","volume":"14","author":"V Rachakonda","year":"2004","unstructured":"Rachakonda V, Pan TH, Le WD: Biomarkers of neurodegenerative disorders: how good are they?. Cell Res. 2004, 14 (5): 347-358. 10.1038\/sj.cr.7290235.","journal-title":"Cell Res"},{"issue":"1","key":"151_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S1474-4422(04)00964-0","volume":"4","author":"CE Teunissen","year":"2005","unstructured":"Teunissen CE, Dijkstra C, Polman C: Biological markers in CSF and blood for axonal degeneration in multiple sclerosis. Lancet Neurol. 2005, 4 (1): 32-41. 10.1016\/S1474-4422(04)00964-0.","journal-title":"Lancet Neurol"},{"issue":"3","key":"151_CR14","doi-asserted-by":"crossref","first-page":"599; author rep","DOI":"10.1212\/WNL.63.3.599","volume":"63","author":"JR Avasarala","year":"2004","unstructured":"Avasarala JR: Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS. Neurology. 2004, 63 (3): 599; author reply 599-","journal-title":"Neurology"},{"issue":"3","key":"151_CR15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02815140","volume":"26","author":"K Blennow","year":"1995","unstructured":"Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E: Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?. Mol Chem Neuropathol. 1995, 26 (3): 231-245.","journal-title":"Mol Chem Neuropathol"},{"issue":"3","key":"151_CR16","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/00006123-198909000-00016","volume":"25","author":"MR Del Bigio","year":"1989","unstructured":"Del Bigio MR: Hydrocephalus-induced changes in the composition of cerebrospinal fluid. Neurosurgery. 1989, 25 (3): 416-423. 10.1097\/00006123-198909000-00016.","journal-title":"Neurosurgery"},{"issue":"8","key":"151_CR17","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00701-005-0526-2","volume":"147","author":"J Sen","year":"2005","unstructured":"Sen J, Belli A, Petzold A, Russo S, Keir G, Thompson EJ, Smith M, Kitchen N: Extracellular fluid S100B in the injured brain: a future surrogate marker of acute brain injury?. Acta Neurochir (Wien). 2005, 147 (8): 897-900. 10.1007\/s00701-005-0526-2.","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"151_CR18","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/00006123-199909000-00012","volume":"45","author":"A Raabe","year":"1999","unstructured":"Raabe A, Grolms C, Sorge O, Zimmermann M, Seifert V: Serum S-100B protein in severe head injury. Neurosurgery. 1999, 45 (3): 477-483. 10.1097\/00006123-199909000-00012.","journal-title":"Neurosurgery"},{"key":"151_CR19","first-page":"112","volume-title":"Physiology of the Cerebrospinal fluid","author":"H Davson","year":"1967","unstructured":"Davson H: The extracellular space of brain and cord. Physiology of the Cerebrospinal fluid. Edited by: Davson H. 1967, London , J & A Churchill, 112-113."},{"issue":"2","key":"151_CR20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1530\/acta.0.1000211","volume":"100","author":"M Hammer","year":"1982","unstructured":"Hammer M, Sorensen PS, Gjerris F, Larsen K: Vasopressin in the cerebrospinal fluid of patients with normal pressure hydrocephalus and benign intracranial hypertension. Acta Endocrinol (Copenh). 1982, 100 (2): 211-215.","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"1-3","key":"151_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0022-510X(83)90189-2","volume":"62","author":"PS Sorensen","year":"1983","unstructured":"Sorensen PS, Gjerris F, Ibsen S, Bock E: Low cerebrospinal fluid concentration of brain-specific protein D2 in patients with normal pressure hydrocephalus. J Neurol Sci. 1983, 62 (1-3): 59-65. 10.1016\/0022-510X(83)90189-2.","journal-title":"J Neurol Sci"},{"issue":"8","key":"151_CR22","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2176\/nmc.31.490","volume":"31","author":"N Yamada","year":"1991","unstructured":"Yamada N, Iwasa H, Mori S, Kurokawa N, Fujimoto K, Kawashima K, Masuzawa T: Melatonin secretion in normal pressure hydrocephalus after cerebral aneurysm rupture--investigation before and after ventriculoperitoneal shunt. Neurol Med Chir (Tokyo). 1991, 31 (8): 490-497.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"3","key":"151_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/BF00313729","volume":"228","author":"C Wikkelso","year":"1982","unstructured":"Wikkelso C, Blomstrand C: Cerebrospinal fluid proteins and cells in normal-pressure hydrocephalus. J Neurol. 1982, 228 (3): 171-180. 10.1007\/BF00313729.","journal-title":"J Neurol"},{"issue":"3 Suppl","key":"151_CR24","first-page":"S40","volume":"57","author":"P Klinge","year":"2005","unstructured":"Klinge P, Marmarou A, Bergsneider M, Relkin N, Black PM: Outcome of shunting in idiopathic normal-pressure hydrocephalus and the value of outcome assessment in shunted patients. Neurosurgery. 2005, 57 (3 Suppl): S40-52; discussion ii-v.","journal-title":"Neurosurgery"},{"issue":"2","key":"151_CR25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000116653","volume":"31","author":"C Wikkelso","year":"1991","unstructured":"Wikkelso C, Ekman R, Westergren I, Johansson B: Neuropeptides in cerebrospinal fluid in normal-pressure hydrocephalus and dementia. Eur Neurol. 1991, 31 (2): 88-93.","journal-title":"Eur Neurol"},{"issue":"3","key":"151_CR26","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1136\/jnnp.70.3.298","volume":"70","author":"MA Poca","year":"2001","unstructured":"Poca MA, Mataro M, Sahuquillo J, Catalan R, Ibanez J, Galard R: Shunt related changes in somatostatin, neuropeptide Y, and corticotropin releasing factor concentrations in patients with normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry. 2001, 70 (3): 298-304. 10.1136\/jnnp.70.3.298.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"151_CR27","doi-asserted-by":"publisher","first-page":"S137","DOI":"10.1016\/0278-5846(88)90077-2","volume":"12 Suppl","author":"DR Rubinow","year":"1988","unstructured":"Rubinow DR, Davis CL, Post RM: Somatostatin in neuropsychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 1988, 12 Suppl: S137-55. 10.1016\/0278-5846(88)90077-2.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"151_CR28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1254\/jjp.32.205","volume":"32","author":"K Ehara","year":"1982","unstructured":"Ehara K, Matsumoto S, Yoshida N, Kuno T, Tanaka C: Ascending norepinephrine pathways impaired in experimental hydrocephalus. Jpn J Pharmacol. 1982, 32 (1): 205-208.","journal-title":"Jpn J Pharmacol"},{"issue":"3","key":"151_CR29","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/BF00319684","volume":"238","author":"A Molins","year":"1991","unstructured":"Molins A, Catalan R, Sahuquillo J, Castellanos JM, Codina A, Galard R: Somatostatin cerebrospinal fluid levels in dementia. J Neurol. 1991, 238 (3): 168-170. 10.1007\/BF00319684.","journal-title":"J Neurol"},{"issue":"3","key":"151_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1043-6618(05)80080-5","volume":"23","author":"G Schettini","year":"1991","unstructured":"Schettini G: Brain somatostatin: receptor-coupled transducing mechanisms and role in cognitive functions. Pharmacol Res. 1991, 23 (3): 203-215. 10.1016\/S1043-6618(05)80080-5.","journal-title":"Pharmacol Res"},{"issue":"4","key":"151_CR31","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1212\/WNL.35.4.592","volume":"35","author":"C Wikkelso","year":"1985","unstructured":"Wikkelso C, Fahrenkrug J, Blomstrand C, Johansson BB: Dementia of different etiologies: vasoactive intestinal polypeptide in CSF. Neurology. 1985, 35 (4): 592-595.","journal-title":"Neurology"},{"issue":"1","key":"151_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0008-6363(00)00229-7","volume":"49","author":"RJ Henning","year":"2001","unstructured":"Henning RJ, Sawmiller DR: Vasoactive intestinal peptide: cardiovascular effects. Cardiovasc Res. 2001, 49 (1): 27-37. 10.1016\/S0008-6363(00)00229-7.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"151_CR33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1136\/jnnp.69.1.74","volume":"69","author":"M Tullberg","year":"2000","unstructured":"Tullberg M, Mansson JE, Fredman P, Lekman A, Blennow K, Ekman R, Rosengren LE, Tisell M, Wikkelso C: CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy. J Neurol Neurosurg Psychiatry. 2000, 69 (1): 74-81. 10.1136\/jnnp.69.1.74.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"151_CR34","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3171\/jns.1983.59.3.0467","volume":"59","author":"LN Sutton","year":"1983","unstructured":"Sutton LN, Wood JH, Brooks BR, Barrer SJ, Kline M, Cohen SR: Cerebrospinal fluid myelin basic protein in hydrocephalus. J Neurosurg. 1983, 59 (3): 467-470.","journal-title":"J Neurosurg"},{"issue":"1","key":"151_CR35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1046\/j.1351-5101.2003.00698.x","volume":"11","author":"M Tisell","year":"2004","unstructured":"Tisell M, Tullberg M, Mansson JE, Fredman P, Blennow K, Wikkelso C: Differences in cerebrospinal fluid dynamics do not affect the levels of biochemical markers in ventricular CSF from patients with aqueductal stenosis and idiopathic normal pressure hydrocephalus. Eur J Neurol. 2004, 11 (1): 17-23. 10.1046\/j.1351-5101.2003.00698.x.","journal-title":"Eur J Neurol"},{"issue":"1","key":"151_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0006-3223(94)90064-7","volume":"36","author":"R Catalan","year":"1994","unstructured":"Catalan R, Sahuquillo J, Poca MA, Molins A, Castellanos JM, Galard R: Neuropeptide Y cerebrospinal fluid levels in patients with normal pressure hydrocephalus syndrome. Biol Psychiatry. 1994, 36 (1): 61-63. 10.1016\/0006-3223(94)90064-7.","journal-title":"Biol Psychiatry"},{"issue":"4","key":"151_CR37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000117347","volume":"30","author":"J Alom","year":"1990","unstructured":"Alom J, Galard R, Catalan R, Castellanos JM, Schwartz S, Tolosa E: Cerebrospinal fluid neuropeptide Y in Alzheimer's disease. Eur Neurol. 1990, 30 (4): 207-210.","journal-title":"Eur Neurol"},{"issue":"3","key":"151_CR38","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/jnnp.54.3.252","volume":"54","author":"J Malm","year":"1991","unstructured":"Malm J, Kristensen B, Ekstedt J, Adolfsson R, Wester P: CSF monoamine metabolites, cholinesterases and lactate in the adult hydrocephalus syndrome (normal pressure hydrocephalus) related to CSF hydrodynamic parameters. J Neurol Neurosurg Psychiatry. 1991, 54 (3): 252-259.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"151_CR39","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1600-0404.1992.tb04056.x","volume":"85","author":"J Hildebrand","year":"1992","unstructured":"Hildebrand J, Moussa Z, Raftopoulos C, Vanhouche J, Laute MA, Przedborski S: Variations of homovanillic acid levels in ventricular cerebrospinal fluid. Acta Neurol Scand. 1992, 85 (5): 340-342.","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"151_CR40","first-page":"293","volume":"4","author":"G Spanu","year":"1989","unstructured":"Spanu G, Santagostino G, Marzatico F, Gaetani P, Silvani V, Rodriguez y Baena R: Idiopathic hydrocephalic dementia in aging brain the neurosurgical approach. Funct Neurol. 1989, 4 (3): 293-298.","journal-title":"Funct Neurol"},{"issue":"3","key":"151_CR41","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000106627","volume":"8","author":"PT Nooijen","year":"1997","unstructured":"Nooijen PT, Schoonderwaldt HC, Wevers RA, Hommes OR, Lamers KJ: Neuron-specific enolase, S-100 protein, myelin basic protein and lactate in CSF in dementia. Dement Geriatr Cogn Disord. 1997, 8 (3): 169-173.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"151_CR42","first-page":"133","volume":"42","author":"E Fersten","year":"2004","unstructured":"Fersten E, Gordon-Krajcer W, Glowacki M, Mroziak B, Jurkiewicz J, Czernicki Z: Cerebrospinal fluid free-radical peroxidation products and cognitive functioning patterns differentiate varieties of normal pressure hydrocephalus. Folia Neuropathol. 2004, 42 (3): 133-140.","journal-title":"Folia Neuropathol"},{"issue":"3","key":"151_CR43","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/BF02260939","volume":"8","author":"K Blennow","year":"1994","unstructured":"Blennow K, Wallin A, Ekman R: Neuron specific enolase in cerebrospinal fluid: a biochemical marker for neuronal degeneration in dementia disorders?. J Neural Transm Park Dis Dement Sect. 1994, 8 (3): 183-191. 10.1007\/BF02260939.","journal-title":"J Neural Transm Park Dis Dement Sect"},{"issue":"1-2","key":"151_CR44","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0304-3940(94)11110-5","volume":"183","author":"L Parnetti","year":"1995","unstructured":"Parnetti L, Palumbo B, Cardinali L, Loreti F, Chionne F, Cecchetti R, Senin U: Cerebrospinal fluid neuron-specific enolase in Alzheimer's disease and vascular dementia. Neurosci Lett. 1995, 183 (1-2): 43-45. 10.1016\/0304-3940(94)11110-5.","journal-title":"Neurosci Lett"},{"issue":"2","key":"151_CR45","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00001721-199404000-00002","volume":"5","author":"R Sutton","year":"1994","unstructured":"Sutton R, Keohane ME, VanderBerg SR, Gonias SL: Plasminogen activator inhibitor-1 in the cerebrospinal fluid as an index of neurological disease. Blood Coagul Fibrinolysis. 1994, 5 (2): 167-171.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"9","key":"151_CR46","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1651-2227.1997.tb15186.x","volume":"86","author":"A Hansen","year":"1997","unstructured":"Hansen A, Whitelaw A, Lapp C, Brugnara C: Cerebrospinal fluid plasminogen activator inhibitor-1: a prognostic factor in posthaemorrhagic hydrocephalus. Acta Paediatr. 1997, 86 (9): 995-998.","journal-title":"Acta Paediatr"},{"issue":"1","key":"151_CR47","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1067\/mpd.2000.106229","volume":"137","author":"AR Hansen","year":"2000","unstructured":"Hansen AR, Lapp C, Brugnara C: Plasminogen activator inhibitor-1: defining characteristics in the cerebrospinal fluid of newborns. J Pediatr. 2000, 137 (1): 132-134. 10.1067\/mpd.2000.106229.","journal-title":"J Pediatr"},{"issue":"4","key":"151_CR48","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.neures.2003.08.009","volume":"47","author":"M Mase","year":"2003","unstructured":"Mase M, Yamada K, Shimazu N, Seiki K, Oda H, Nakau H, Inui T, Li W, Eguchi N, Urade Y: Lipocalin-type prostaglandin D synthase (beta-trace) in cerebrospinal fluid: a useful marker for the diagnosis of normal pressure hydrocephalus. Neurosci Res. 2003, 47 (4): 455-459. 10.1016\/j.neures.2003.08.009.","journal-title":"Neurosci Res"},{"issue":"6","key":"151_CR49","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1469-8749.1985.tb03806.x","volume":"27","author":"SD Levin","year":"1985","unstructured":"Levin SD, Hoyle NR, Brown JK, Thomas DG: Cerebrospinal fluid myelin basic protein immunoreactivity as an indicator of brain damage in children. Dev Med Child Neurol. 1985, 27 (6): 807-813.","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"151_CR50","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/ana.410070111","volume":"7","author":"JN Whitaker","year":"1980","unstructured":"Whitaker JN, Lisak RP, Bashir RM, Fitch OH, Seyer JM, Krance R, Lawrence JA, Ch'ien LT, O'Sullivan P: Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disorders. Ann Neurol. 1980, 7 (1): 58-64. 10.1002\/ana.410070111.","journal-title":"Ann Neurol"},{"issue":"2","key":"151_CR51","first-page":"87","volume":"37","author":"PL Longatti","year":"1993","unstructured":"Longatti PL, Canova G, Guida F, Carniato A, Moro M, Carteri A: The CSF myelin basic protein: a reliable marker of actual cerebral damage in hydrocephalus. J Neurosurg Sci. 1993, 37 (2): 87-90.","journal-title":"J Neurosurg Sci"},{"issue":"3","key":"151_CR52","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/S0967-5868(03)00019-5","volume":"10","author":"N Fukushima","year":"2003","unstructured":"Fukushima N, Yokouchi K, Kawagishi K, Ren G, Higashiyama F, Moriizumi T: Proliferating cell populations in experimentally-induced hydrocephalus in developing rats. J Clin Neurosci. 2003, 10 (3): 334-337. 10.1016\/S0967-5868(03)00019-5.","journal-title":"J Clin Neurosci"},{"issue":"2","key":"151_CR53","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1017\/S0317167100021442","volume":"24","author":"MR Del Bigio","year":"1997","unstructured":"Del Bigio MR, Cardoso ER, Halliday WC: Neuropathological changes in chronic adult hydrocephalus: cortical biopsies and autopsy findings. Can J Neurol Sci. 1997, 24 (2): 121-126.","journal-title":"Can J Neurol Sci"},{"key":"151_CR54","first-page":"236","volume":"49 Suppl 1","author":"K Sendrowski","year":"2004","unstructured":"Sendrowski K, Sobaniec W, Sobaniec-Lotowska ME, Lewczuk P: S-100 protein as marker of the blood-brain barrier disruption in children with internal hydrocephalus and epilepsy--a preliminary study. Rocz Akad Med Bialymst. 2004, 49 Suppl 1: 236-238.","journal-title":"Rocz Akad Med Bialymst"},{"issue":"1-2","key":"151_CR55","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0304-3940(98)01001-5","volume":"261","author":"A Migheli","year":"1999","unstructured":"Migheli A, Cordera S, Bendotti C, Atzori C, Piva R, Schiffer D: S-100beta protein is upregulated in astrocytes and motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis. Neurosci Lett. 1999, 261 (1-2): 25-28. 10.1016\/S0304-3940(98)01001-5.","journal-title":"Neurosci Lett"},{"issue":"8","key":"151_CR56","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1468-1331.2005.01044.x","volume":"12","author":"F Mashayekhi","year":"2005","unstructured":"Mashayekhi F, Salehi Z: Expression of nerve growth factor in cerebrospinal fluid of congenital hydrocephalic and normal children. Eur J Neurol. 2005, 12 (8): 632-637. 10.1111\/j.1468-1331.2005.01044.x.","journal-title":"Eur J Neurol"},{"issue":"12","key":"151_CR57","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1007\/s00381-001-0515-6","volume":"17","author":"M Shinoda","year":"2001","unstructured":"Shinoda M, Hidaka M, Lindqvist E, Soderstrom S, Matsumae M, Oi S, Sato O, Tsugane R, Ebendal T, Olson L: NGF, NT-3 and Trk C mRNAs, but not TrkA mRNA, are upregulated in the paraventricular structures in experimental hydrocephalus. Childs Nerv Syst. 2001, 17 (12): 704-712. 10.1007\/s00381-001-0515-6.","journal-title":"Childs Nerv Syst"},{"issue":"8","key":"151_CR58","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0009-9120(99)00077-6","volume":"32","author":"JT Yang","year":"1999","unstructured":"Yang JT, Chang CN, Hsu YH, Wei KC, Lin TK, Wu JH: Increase in CSF NGF concentration is positively correlated with poor prognosis of postoperative hydrocephalic patients. Clin Biochem. 1999, 32 (8): 673-675. 10.1016\/S0009-9120(99)00077-6.","journal-title":"Clin Biochem"},{"key":"151_CR59","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2431-1-2","volume":"1","author":"F Hochhaus","year":"2001","unstructured":"Hochhaus F, Koehne P, Schaper C, Butenandt O, Felderhoff-Mueser U, Ring-Mrozik E, Obladen M, Buhrer C: Elevated nerve growth factor and neurotrophin-3 levels in cerebrospinal fluid of children with hydrocephalus. BMC Pediatr. 2001, 1: 2-10.1186\/1471-2431-1-2.","journal-title":"BMC Pediatr"},{"issue":"2","key":"151_CR60","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1046\/j.1440-1819.2000.00658.x","volume":"54","author":"T Kudo","year":"2000","unstructured":"Kudo T, Mima T, Hashimoto R, Nakao K, Morihara T, Tanimukai H, Tsujio I, Koike Y, Tagami S, Mori H, Nakamura Y, Tanaka T, Mori K, Takeda M: Tau protein is a potential biological marker for normal pressure hydrocephalus. Psychiatry Clin Neurosci. 2000, 54 (2): 199-202. 10.1046\/j.1440-1819.2000.00658.x.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"2","key":"151_CR61","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00401-005-1027-3","volume":"110","author":"J Newman","year":"2005","unstructured":"Newman J, Rissman RA, Sarsoza F, Kim RC, Dick M, Bennett DA, Cotman CW, Rohn TT, Head E: Caspase-cleaved tau accumulation in neurodegenerative diseases associated with tau and alpha-synuclein pathology. Acta Neuropathol (Berl). 2005, 110 (2): 135-144. 10.1007\/s00401-005-1027-3.","journal-title":"Acta Neuropathol (Berl)"},{"issue":"5","key":"151_CR62","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.clineuro.2004.12.002","volume":"107","author":"B Van Everbroeck","year":"2005","unstructured":"Van Everbroeck B, Boons J, Cras P: Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease. Clin Neurol Neurosurg. 2005, 107 (5): 355-360. 10.1016\/j.clineuro.2004.12.002.","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"151_CR63","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00702-003-0075-x","volume":"111","author":"H Lins","year":"2004","unstructured":"Lins H, Wichart I, Bancher C, Wallesch CW, Jellinger KA, Rosler N: Immunoreactivities of amyloid beta peptide((1-42)) and total tau protein in lumbar cerebrospinal fluid of patients with normal pressure hydrocephalus. J Neural Transm. 2004, 111 (3): 273-280. 10.1007\/s00702-003-0075-x.","journal-title":"J Neural Transm"},{"issue":"3","key":"151_CR64","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1212\/WNL.52.3.547","volume":"52","author":"SC Samuels","year":"1999","unstructured":"Samuels SC, Silverman JM, Marin DB, Peskind ER, Younki SG, Greenberg DA, Schnur E, Santoro J, Davis KL: CSF beta-amyloid, cognition, and APOE genotype in Alzheimer's disease. Neurology. 1999, 52 (3): 547-551.","journal-title":"Neurology"},{"issue":"6","key":"151_CR65","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/00001756-200604240-00020","volume":"17","author":"PM Klinge","year":"2006","unstructured":"Klinge PM, Samii A, Niescken S, Brinker T, Silverberg GD: Brain amyloid accumulates in aged rats with kaolin-induced hydrocephalus. Neuroreport. 2006, 17 (6): 657-660. 10.1097\/00001756-200604240-00020.","journal-title":"Neuroreport"},{"key":"151_CR66","first-page":"389","volume":"56","author":"H Bartosik-Psujek","year":"2001","unstructured":"Bartosik-Psujek H, Stelmasiak Z: Biochemical markers of damage of the central nervous system in multiple sclerosis. Ann Univ Mariae Curie Sklodowska [Med]. 2001, 56: 389-392.","journal-title":"Ann Univ Mariae Curie Sklodowska [Med]"},{"key":"151_CR67","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1212\/01.WNL.0000098880.19793.B6","volume":"61","author":"C Malmestrom","year":"2003","unstructured":"Malmestrom C, Haghighi S, Rosengren L, Andersen O, Lycke J: Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS. Neurology. 2003, 61: 1720-1725.","journal-title":"Neurology"},{"issue":"4","key":"151_CR68","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1212\/WNL.50.4.1122","volume":"50","author":"M Tullberg","year":"1998","unstructured":"Tullberg M, Rosengren L, Blomsterwall E, Karlsson JE, Wikkelso C: CSF neurofilament and glial fibrillary acidic protein in normal pressure hydrocephalus. Neurology. 1998, 50 (4): 1122-1127.","journal-title":"Neurology"},{"issue":"3","key":"151_CR69","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0022-510X(85)90168-6","volume":"70","author":"M Albrechtsen","year":"1985","unstructured":"Albrechtsen M, Sorensen PS, Gjerris F, Bock E: High cerebrospinal fluid concentration of glial fibrillary acidic protein (GFAP) in patients with normal pressure hydrocephalus. J Neurol Sci. 1985, 70 (3): 269-274. 10.1016\/0022-510X(85)90168-6.","journal-title":"J Neurol Sci"},{"issue":"3","key":"151_CR70","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1017\/S0317167100030614","volume":"17","author":"G Lacoste-Royal","year":"1990","unstructured":"Lacoste-Royal G, Mathieu M, Nalbantoglu J, Julien JP, Gauthier S, Gauvreau D: Lack of association between two restriction fragment length polymorphisms in the genes for the light and heavy neurofilament proteins and Alzheimer's disease. Can J Neurol Sci. 1990, 17 (3): 302-305.","journal-title":"Can J Neurol Sci"},{"issue":"4","key":"151_CR71","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/glia.20292","volume":"53","author":"J Marcus","year":"2006","unstructured":"Marcus J, Honigbaum S, Shroff S, Honke K, Rosenbluth J, Dupree JL: Sulfatide is essential for the maintenance of CNS myelin and axon structure. Glia. 2006, 53 (4): 372-381. 10.1002\/glia.20292.","journal-title":"Glia"},{"issue":"3-4","key":"151_CR72","first-page":"78","volume":"58","author":"T Kovacs","year":"2005","unstructured":"Kovacs T, Szirmai I, Papp M: [Clinico-pathology and differential diagnosis of Binswanger's disease]. Ideggyogy Sz. 2005, 58 (3-4): 78-87.","journal-title":"Ideggyogy Sz"},{"issue":"5","key":"151_CR73","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S0197-4580(02)00187-2","volume":"24","author":"E Tarkowski","year":"2003","unstructured":"Tarkowski E, Tullberg M, Fredman P, Wikkelso C: Normal pressure hydrocephalus triggers intrathecal production of TNF-alpha. Neurobiol Aging. 2003, 24 (5): 707-714. 10.1016\/S0197-4580(02)00187-2.","journal-title":"Neurobiol Aging"},{"issue":"10","key":"151_CR74","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1001\/archneur.62.10.1591","volume":"62","author":"K Stoeck","year":"2005","unstructured":"Stoeck K, Bodemer M, Ciesielczyk B, Meissner B, Bartl M, Heinemann U, Zerr I: Interleukin 4 and interleukin 10 levels are elevated in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Arch Neurol. 2005, 62 (10): 1591-1594. 10.1001\/archneur.62.10.1591.","journal-title":"Arch Neurol"},{"issue":"7","key":"151_CR75","first-page":"455","volume":"13","author":"R Cacabelos","year":"1991","unstructured":"Cacabelos R, Barquero M, Garcia P, Alvarez XA, Varela de Seijas E: Cerebrospinal fluid interleukin-1 beta (IL-1 beta) in Alzheimer's disease and neurological disorders. Methods Find Exp Clin Pharmacol. 1991, 13 (7): 455-458.","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"3","key":"151_CR76","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2174\/1568026053544515","volume":"5","author":"C Mollereau","year":"2005","unstructured":"Mollereau C, Roumy M, Zajac JM: Opioid-modulating peptides: mechanisms of action. Curr Top Med Chem. 2005, 5 (3): 341-355. 10.2174\/1568026053544515.","journal-title":"Curr Top Med Chem"},{"issue":"7","key":"151_CR77","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S0006-3223(96)00098-4","volume":"41","author":"R Galard","year":"1997","unstructured":"Galard R, Poca MA, Catalan R, Tintore M, Castellanos JM, Sahuquillo J: Decreased cholecystokinin levels in cerebrospinal fluid of patients with adult chronic hydrocephalus syndrome. Biol Psychiatry. 1997, 41 (7): 804-809. 10.1016\/S0006-3223(96)00098-4.","journal-title":"Biol Psychiatry"},{"issue":"11","key":"151_CR78","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1136\/jnnp.2003.026013","volume":"75","author":"J Brettschneider","year":"2004","unstructured":"Brettschneider J, Riepe MW, Petereit HF, Ludolph AC, Tumani H: Meningeal derived cerebrospinal fluid proteins in different forms of dementia: is a meningopathy involved in normal pressure hydrocephalus?. J Neurol Neurosurg Psychiatry. 2004, 75 (11): 1614-1616. 10.1136\/jnnp.2003.026013.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"151_CR79","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1001\/archneur.58.3.373","volume":"58","author":"N Andreasen","year":"2001","unstructured":"Andreasen N, Minthon L, Davidsson P, Vanmechelen E, Vanderstichele H, Winblad B, Blennow K: Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice. Arch Neurol. 2001, 58 (3): 373-379. 10.1001\/archneur.58.3.373.","journal-title":"Arch Neurol"},{"issue":"Pt 8","key":"151_CR80","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1093\/brain\/awh198","volume":"127","author":"AW Michell","year":"2004","unstructured":"Michell AW, Lewis SJ, Foltynie T, Barker RA: Biomarkers and Parkinson's disease. Brain. 2004, 127 (Pt 8): 1693-1705. 10.1093\/brain\/awh198.","journal-title":"Brain"},{"issue":"2-3","key":"151_CR81","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000083178","volume":"19","author":"B Mollenhauer","year":"2005","unstructured":"Mollenhauer B, Cepek L, Bibl M, Wiltfang J, Schulz-Schaeffer WJ, Ciesielczyk B, Neumann M, Steinacker P, Kretzschmar HA, Poser S, Trenkwalder C, Otto M: Tau protein, Abeta42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies. Dement Geriatr Cogn Disord. 2005, 19 (2-3): 164-170. 10.1159\/000083178.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"6","key":"151_CR82","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s007010050353","volume":"141","author":"RA Bech","year":"1999","unstructured":"Bech RA, Waldemar G, Gjerris F, Klinken L, Juhler M: Shunting effects in patients with idiopathic normal pressure hydrocephalus; correlation with cerebral and leptomeningeal biopsy findings. Acta Neurochir (Wien). 1999, 141 (6): 633-639. 10.1007\/s007010050353.","journal-title":"Acta Neurochir (Wien)"},{"issue":"6","key":"151_CR83","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00701-002-0936-3","volume":"144","author":"S Savolainen","year":"2002","unstructured":"Savolainen S, Hurskainen H, Paljarvi L, Alafuzoff I, Vapalahti M: Five-year outcome of normal pressure hydrocephalus with or without a shunt: predictive value of the clinical signs, neuropsychological evaluation and infusion test. Acta Neurochir (Wien). 2002, 144 (6): 515-23; discussion 523. 10.1007\/s00701-002-0936-3.","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"151_CR84","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1055\/s-2003-40733","volume":"46","author":"A Holm","year":"2003","unstructured":"Holm A, Savolainen S, Alafuzoff I: Brain biopsy prior to treatment of Alzheimer's disease. Minim Invasive Neurosurg. 2003, 46 (3): 161-164. 10.1055\/s-2003-40733.","journal-title":"Minim Invasive Neurosurg"},{"issue":"8","key":"151_CR85","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/S1474-4422(03)00487-3","volume":"2","author":"GD Silverberg","year":"2003","unstructured":"Silverberg GD, Mayo M, Saul T, Rubenstein E, McGuire D: Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis. Lancet Neurol. 2003, 2 (8): 506-511. 10.1016\/S1474-4422(03)00487-3.","journal-title":"Lancet Neurol"},{"issue":"8","key":"151_CR86","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1212\/01.WNL.0000031794.42077.A1","volume":"59","author":"GD Silverberg","year":"2002","unstructured":"Silverberg GD, Levinthal E, Sullivan EV, Bloch DA, Chang SD, Leverenz J, Flitman S, Winn R, Marciano F, Saul T, Huhn S, Mayo M, McGuire D: Assessment of low-flow CSF drainage as a treatment for AD: results of a randomized pilot study. Neurology. 2002, 59 (8): 1139-1145.","journal-title":"Neurology"},{"issue":"1","key":"151_CR87","first-page":"97","volume":"37","author":"K Akai","year":"1987","unstructured":"Akai K, Uchigasaki S, Tanaka U, Komatsu A: Normal pressure hydrocephalus. Neuropathological study. Acta Pathol Jpn. 1987, 37 (1): 97-110.","journal-title":"Acta Pathol Jpn"},{"issue":"4","key":"151_CR88","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00005072-197110000-00006","volume":"30","author":"RO Weller","year":"1971","unstructured":"Weller RO, Wisniewski H, Shulman K, Terry RD: Experimental hydrocephalus in young dogs: histological and ultrastructural study of the brain tissue damage. J Neuropathol Exp Neurol. 1971, 30 (4): 613-626.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"151_CR89","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2176\/nmc.21.75","volume":"21","author":"M Miyagami","year":"1981","unstructured":"Miyagami M, Murakami T, Wakamatsu K, Kondo T, Takeuchi T, Tsubokawa T, Moriyasu N: Experimental and clinical studies on prognosis deteriorating factors in the acute stage of intraventricular hemorrhage. Neurol Med Chir (Tokyo). 1981, 21 (1): 75-83.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"3","key":"151_CR90","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1148\/radiology.135.3.6770414","volume":"135","author":"AEJ James","year":"1980","unstructured":"James AEJ, Flor WJ, Novak GR, Ribas JL, Parker JL, Sickel WL: The ultrastructural basis of periventricular edema: preliminary studies. Radiology. 1980, 135 (3): 747-750.","journal-title":"Radiology"},{"issue":"1","key":"151_CR91","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1161\/01.STR.0000048820.17198.15","volume":"34","author":"PM Klinge","year":"2003","unstructured":"Klinge PM, Samii A, Muhlendyck A, Visnyei K, Meyer GJ, Walter GF, Silverberg GD, Brinker T: Cerebral hypoperfusion and delayed hippocampal response after induction of adult kaolin hydrocephalus. Stroke. 2003, 34 (1): 193-199. 10.1161\/01.STR.0000048820.17198.15.","journal-title":"Stroke"},{"key":"151_CR92","first-page":"275","volume":"81","author":"P Klinge","year":"2002","unstructured":"Klinge P, Muhlendyck A, Lee S, Ludemann W, Groos S, Samii M, Brinker T: Temporal and regional profile of neuronal and glial cellular injury after induction of kaolin hydrocephalus. Acta Neurochir Suppl. 2002, 81: 275-277.","journal-title":"Acta Neurochir Suppl"},{"issue":"1","key":"151_CR93","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1006\/exnr.1998.6922","volume":"154","author":"MR Del Bigio","year":"1998","unstructured":"Del Bigio MR, Zhang YW: Cell death, axonal damage, and cell birth in the immature rat brain following induction of hydrocephalus. Exp Neurol. 1998, 154 (1): 157-169. 10.1006\/exnr.1998.6922.","journal-title":"Exp Neurol"},{"issue":"5","key":"151_CR94","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1365-2702.2004.00910.x","volume":"13","author":"L Gelling","year":"2004","unstructured":"Gelling L, Iddon J, McVicar A, Pickard JD: CSF circulation disorders: measuring progress in patients through quality of life and hope. J Clin Nurs. 2004, 13 (5): 589-600. 10.1111\/j.1365-2702.2004.00910.x.","journal-title":"J Clin Nurs"},{"issue":"1","key":"151_CR95","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1046\/j.1471-4159.2003.01656.x","volume":"85","author":"D Kondziella","year":"2003","unstructured":"Kondziella D, Qu H, Ludemann W, Brinker T, Sletvold O, Sonnewald U: Astrocyte metabolism is disturbed in the early development of experimental hydrocephalus. J Neurochem. 2003, 85 (1): 274-281.","journal-title":"J Neurochem"},{"issue":"4","key":"151_CR96","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2176\/nmc.44.222","volume":"44","author":"M Ishikawa","year":"2004","unstructured":"Ishikawa M: Clinical guidelines for idiopathic normal pressure hydrocephalus. Neurol Med Chir (Tokyo). 2004, 44 (4): 222-223. 10.2176\/nmc.44.222.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"3","key":"151_CR97","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1191\/135245898678909439","volume":"4","author":"H Reiber","year":"1998","unstructured":"Reiber H: Cerebrospinal fluid--physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult Scler. 1998, 4 (3): 99-107. 10.1191\/135245898678909439.","journal-title":"Mult Scler"},{"issue":"6","key":"151_CR98","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1212\/WNL.30.6.645","volume":"30","author":"JH Wood","year":"1980","unstructured":"Wood JH: Neurochemical analysis of cerebrospinal fluid. Neurology. 1980, 30 (6): 645-651.","journal-title":"Neurology"},{"issue":"6","key":"151_CR99","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/clinchem\/38.6.813","volume":"38","author":"BG van Engelen","year":"1992","unstructured":"van Engelen BG, Lamers KJ, Gabreels FJ, Wevers RA, van Geel WJ, Borm GF: Age-related changes of neuron-specific enolase, S-100 protein, and myelin basic protein concentrations in cerebrospinal fluid. Clin Chem. 1992, 38 (6): 813-816.","journal-title":"Clin Chem"},{"issue":"6","key":"151_CR100","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1600-0447.1987.tb02846.x","volume":"75","author":"A Gjerris","year":"1987","unstructured":"Gjerris A, Werdelin L, Gjerris F, Sorensen PS, Rafaelsen OJ, Alling C: CSF-amine metabolites in depression, dementia and in controls. Acta Psychiatr Scand. 1987, 75 (6): 619-628.","journal-title":"Acta Psychiatr Scand"},{"issue":"1-2","key":"151_CR101","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF01400529","volume":"91","author":"A Gjerris","year":"1988","unstructured":"Gjerris A, Gjerris F, Sorensen PS, Sorensen EB, Christensen NJ, Fahrenkrug J, Rehfeld JF: Do concentrations of neurotransmitters measured in lumbar cerebrospinal fluid reflect the concentrations at brain level?. Acta Neurochir (Wien). 1988, 91 (1-2): 55-59. 10.1007\/BF01400529.","journal-title":"Acta Neurochir (Wien)"},{"issue":"2","key":"151_CR102","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0009-8981(01)00573-3","volume":"310","author":"H Reiber","year":"2001","unstructured":"Reiber H: Dynamics of brain-derived proteins in cerebrospinal fluid. Clin Chim Acta. 2001, 310 (2): 173-186. 10.1016\/S0009-8981(01)00573-3.","journal-title":"Clin Chim Acta"},{"key":"151_CR103","first-page":"271","volume":"81","author":"W Luedemann","year":"2002","unstructured":"Luedemann W, Kondziella D, Tienken K, Klinge P, Brinker T, Berens von Rautenfeld D: Spinal cerebrospinal fluid pathways and their significance for the compensation of kaolin-hydrocephalus. Acta Neurochir Suppl. 2002, 81: 271-273.","journal-title":"Acta Neurochir Suppl"},{"issue":"2","key":"151_CR104","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/jnnp.74.2.217","volume":"74","author":"A Agren-Wilsson","year":"2003","unstructured":"Agren-Wilsson A, Roslin M, Eklund A, Koskinen LO, Bergenheim AT, Malm J: Intracerebral microdialysis and CSF hydrodynamics in idiopathic adult hydrocephalus syndrome. J Neurol Neurosurg Psychiatry. 2003, 74 (2): 217-221. 10.1136\/jnnp.74.2.217.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"151_CR105","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1136\/jnnp.2004.042838","volume":"76","author":"A Agren-Wilsson","year":"2005","unstructured":"Agren-Wilsson A, Eklund A, Koskinen LO, Bergenheim AT, Malm J: Brain energy metabolism and intracranial pressure in idiopathic adult hydrocephalus syndrome. J Neurol Neurosurg Psychiatry. 2005, 76 (8): 1088-1093. 10.1136\/jnnp.2004.042838.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"151_CR106","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1210\/jc.74.6.1325","volume":"74","author":"TDJ Geracioti","year":"1992","unstructured":"Geracioti TDJ, Orth DN, Ekhator NN, Blumenkopf B, Loosen PT: Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans. J Clin Endocrinol Metab. 1992, 74 (6): 1325-1330. 10.1210\/jc.74.6.1325.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"151_CR107","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s10143-004-0341-x","volume":"27","author":"C Woertgen","year":"2004","unstructured":"Woertgen C, Albert R, Kohler M, Rzepecki A, Rothoerl RD, Bein T, Brawanski A: Ventricular tapping seems to have no influence on S-100B and NSE serum concentrations. Neurosurg Rev. 2004, 27 (3): 178-180. 10.1007\/s10143-004-0341-x.","journal-title":"Neurosurg Rev"},{"issue":"3-4","key":"151_CR108","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/BF01400675","volume":"110","author":"A Kruse","year":"1991","unstructured":"Kruse A, Cesarini KG, Bach FW, Persson L: Increases of neuron-specific enolase, S-100 protein, creatine kinase and creatine kinase BB isoenzyme in CSF following intraventricular catheter implantation. Acta Neurochir (Wien). 1991, 110 (3-4): 106-109. 10.1007\/BF01400675.","journal-title":"Acta Neurochir (Wien)"},{"key":"151_CR109","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/02648725.1996.10647923","volume":"13","author":"MR Wilkins","year":"1996","unstructured":"Wilkins MR, Sanchez JC, Gooley AA, Appel RD, Humphery-Smith I, Hochstrasser DF, Williams KL: Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. Biotechnol Genet Eng Rev. 1996, 13: 19-50.","journal-title":"Biotechnol Genet Eng Rev"},{"issue":"1","key":"151_CR110","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1021\/pr034070r","volume":"3","author":"BR Wenner","year":"2004","unstructured":"Wenner BR, Lovell MA, Lynn BC: Proteomic analysis of human ventricular cerebrospinal fluid from neurologically normal, elderly subjects using two-dimensional LC-MS\/MS. J Proteome Res. 2004, 3 (1): 97-103. 10.1021\/pr034070r.","journal-title":"J Proteome Res"},{"issue":"15","key":"151_CR111","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1002\/elps.200406012","volume":"25","author":"EJ Finehout","year":"2004","unstructured":"Finehout EJ, Franck Z, Lee KH: Towards two-dimensional electrophoresis mapping of the cerebrospinal fluid proteome from a single individual. Electrophoresis. 2004, 25 (15): 2564-2575. 10.1002\/elps.200406012.","journal-title":"Electrophoresis"},{"issue":"14","key":"151_CR112","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1002\/elps.200305909","volume":"25","author":"G Maccarrone","year":"2004","unstructured":"Maccarrone G, Milfay D, Birg I, Rosenhagen M, Holsboer F, Grimm R, Bailey J, Zolotarjova N, Turck CW: Mining the human cerebrospinal fluid proteome by immunodepletion and shotgun mass spectrometry. Electrophoresis. 2004, 25 (14): 2402-2412. 10.1002\/elps.200305909.","journal-title":"Electrophoresis"},{"issue":"2","key":"151_CR113","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/jms.737","volume":"40","author":"X Yuan","year":"2005","unstructured":"Yuan X, Desiderio DM: Human cerebrospinal fluid peptidomics. J Mass Spectrom. 2005, 40 (2): 176-181. 10.1002\/jms.737.","journal-title":"J Mass Spectrom"},{"issue":"2","key":"151_CR114","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/pmic.200400934","volume":"5","author":"X Yuan","year":"2005","unstructured":"Yuan X, Desiderio DM: Proteomics analysis of prefractionated human lumbar cerebrospinal fluid. Proteomics. 2005, 5 (2): 541-550. 10.1002\/pmic.200400934.","journal-title":"Proteomics"},{"issue":"6","key":"151_CR115","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1080\/13550280500385237","volume":"11","author":"JR Berger","year":"2005","unstructured":"Berger JR, Avison M, Mootoor Y, Beach C: Cerebrospinal fluid proteomics and human immunodeficiency virus dementia: preliminary observations. J Neurovirol. 2005, 11 (6): 557-562. 10.1080\/13550280500385237.","journal-title":"J Neurovirol"},{"issue":"3","key":"151_CR116","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1191\/1352458504ms1023oa","volume":"10","author":"BN Hammack","year":"2004","unstructured":"Hammack BN, Fung KY, Hunsucker SW, Duncan MW, Burgoon MP, Owens GP, Gilden DH: Proteomic analysis of multiple sclerosis cerebrospinal fluid. Mult Scler. 2004, 10 (3): 245-260. 10.1191\/1352458504ms1023oa.","journal-title":"Mult Scler"},{"issue":"1-2","key":"151_CR117","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.molbrainres.2003.08.005","volume":"118","author":"M Puchades","year":"2003","unstructured":"Puchades M, Hansson SF, Nilsson CL, Andreasen N, Blennow K, Davidsson P: Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease. Brain Res Mol Brain Res. 2003, 118 (1-2): 140-146. 10.1016\/j.molbrainres.2003.08.005.","journal-title":"Brain Res Mol Brain Res"},{"issue":"8","key":"151_CR118","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/jnen\/62.8.855","volume":"62","author":"PP Zheng","year":"2003","unstructured":"Zheng PP, Luider TM, Pieters R, Avezaat CJ, van den Bent MJ, Sillevis Smitt PA, Kros JM: Identification of tumor-related proteins by proteomic analysis of cerebrospinal fluid from patients with primary brain tumors. J Neuropathol Exp Neurol. 2003, 62 (8): 855-862.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"151_CR119","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/00001756-200504250-00011","volume":"16","author":"X Li","year":"2005","unstructured":"Li X, Miyajima M, Mineki R, Taka H, Murayama K, Arai H: Analysis of cerebellum proteomics in the hydrocephalic H-Tx rat. Neuroreport. 2005, 16 (6): 571-574. 10.1097\/00001756-200504250-00011.","journal-title":"Neuroreport"},{"issue":"3","key":"151_CR120","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0014-5793(02)03686-4","volume":"532","author":"O Burlet-Schiltz","year":"2002","unstructured":"Burlet-Schiltz O, Mazarguil H, Sol JC, Chaynes P, Monsarrat B, Zajac JM, Roussin A: Identification of neuropeptide FF-related peptides in human cerebrospinal fluid by mass spectrometry. FEBS Lett. 2002, 532 (3): 313-318. 10.1016\/S0014-5793(02)03686-4.","journal-title":"FEBS Lett"}],"container-title":["Cerebrospinal Fluid Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-8454-3-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1743-8454-3-11\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-8454-3-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T12:01:55Z","timestamp":1587211315000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/1743-8454-3-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,4]]},"references-count":120,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["151"],"URL":"https:\/\/doi.org\/10.1186\/1743-8454-3-11","relation":{},"ISSN":["1743-8454"],"issn-type":[{"value":"1743-8454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,4]]},"article-number":"11"}}